Northwestern University scientists have demonstrated the first genetic-based approach that is able to detect live circulating tumor cells out of the complex matrix that is human blood. The NanoFlare technology potentially could detect cancer cells long before they could settle somewhere in the body and form a dangerous tumor.
Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.